021-51111890
购物车（）
sales@molnova.cn
5-O-Coumaroylquinic acid
CAS No. 32451-86-8
5-O-Coumaroylquinic acid ( —— )
产品货号. M32480 CAS No. 32451-86-8
5-O-Coumaroylquinic acid has a considerable inhibitory effect on PTP1B.5-O-Coumaroylquinic acid( 3-O-Coumaroylquinic acid) shows a significant concentration-dependent inhibitory effect on α-glucosidase, so it has anti-hyperglycemic effect.5-O-Coumaroylquinic acid(3-O-Coumaroylquinine acid) enhances glucose uptake and inhibits PTP1B in vitro.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4040 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称5-O-Coumaroylquinic acid
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述5-O-Coumaroylquinic acid has a considerable inhibitory effect on PTP1B.5-O-Coumaroylquinic acid( 3-O-Coumaroylquinic acid) shows a significant concentration-dependent inhibitory effect on α-glucosidase, so it has anti-hyperglycemic effect.5-O-Coumaroylquinic acid(3-O-Coumaroylquinine acid) enhances glucose uptake and inhibits PTP1B in vitro.
-
产品描述5-O-Coumaroylquinic acid has a considerable inhibitory effect on PTP1B.5-O-Coumaroylquinic acid( 3-O-Coumaroylquinic acid) shows a significant concentration-dependent inhibitory effect on α-glucosidase, so it has anti-hyperglycemic effect.5-O-Coumaroylquinic acid(3-O-Coumaroylquinine acid) enhances glucose uptake and inhibits PTP1B in vitro.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number32451-86-8
-
分子量338.3
-
分子式C16H18O8
-
纯度>98% (HPLC)
-
溶解度DMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.J Ethnopharmacol . 2014 Mar 28;152(3):599-602.
产品手册
关联产品
-
12-hydroxy Stearic A...
12-Hydroxystearic acid 是一种结构简单、成本低廉的低分子量有机凝胶剂，其金属盐和衍生物在许多重要应用中发挥着重要作用。
-
Secretin (28-54), hu...
Secretin (28-54), human, which acts on human secretin receptors, is a 27-amino acid residue C-terminally amidated peptide, .
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
